Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1951
|
| gptkbp:ATCCode |
R06AD02
|
| gptkbp:CASNumber |
60-87-7
|
| gptkbp:cause |
seizures
photosensitivity neuroleptic malignant syndrome tardive dyskinesia |
| gptkbp:chemicalFormula |
C17H20N2S
|
| gptkbp:contraindication |
children under 2 years
severe respiratory depression hypersensitivity to promethazine |
| gptkbp:drugClass |
antihistamine
antiemetic phenothiazine derivative |
| gptkbp:eliminationHalfLife |
10-19 hours
|
| gptkbp:genericName |
gptkb:promethazine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Phenergan
|
| gptkbp:interactsWith |
gptkb:beer
gptkb:MAO_inhibitors gptkb:CNS_depressants anticholinergic drugs |
| gptkbp:legalStatus |
Rx-only (US)
POM (UK) |
| gptkbp:manufacturer |
gptkb:Wyeth
|
| gptkbp:MedlinePlusID |
a682284
|
| gptkbp:metabolism |
liver
|
| gptkbp:overdoseSymptoms |
delirium
cardiac arrest respiratory depression hallucinations convulsions CNS depression |
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:PubChem_CID |
4927
|
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous rectal |
| gptkbp:sideEffect |
constipation
dizziness blurred vision drowsiness respiratory depression dry mouth |
| gptkbp:UNII |
SZZ43629ES
|
| gptkbp:usedFor |
nausea
vomiting cough sedation motion sickness allergy symptoms preoperative sedation |
| gptkbp:bfsParent |
gptkb:promethazine
gptkb:Promethazine |
| gptkbp:bfsLayer |
7
|